MédiMabs – CCAB series launch

MédiMabs is pleased to announce you that we have set an official agreement with the CCAB for the commercialization of their research reagents under the brand . We are starting with 19 new antibodies against various cell surface targets + an antibody panel against 6 different FGFR isoforms. All of these high quality antibodies were developed by CCAB on their phage display platform. You can read the  on CCAB website.

Written by
MédiMabs’ Team
Change my preferences
+

We use cookies to facilitate your navigation and enable certain features. You can see detailed information about all cookies in each consent category below.

Functional cookies (Required)

These cookies are essential for the proper functioning of our website; that’s why you can’t delete them.

  • Cookie

    _rubiskuit

  • Duration

    30 days

  • Description

    Ce fichier témoin est utilisé pour connaître les préférences de fichiers témoins de l’utilisateur.

  • Cookie

    pll_language

  • Duration

    1 year

  • Description

    Ce cookie est utilisé pour connaître les préférences linguistiques de l’utilisateur.

Statistical cookies

These cookies allow us to know the use made of our site and its performance, to establish usage statistics and to determine the volumes of attendance and use of the various elements.

Advertising cookies

These cookies are used to provide visitors with personalized advertisements based on previously visited pages and to analyze the effectiveness of the advertising campaign.

  • Cookie

    Facebook pixel (_fbp)

  • Duration

    3 months

  • Description

    This cookie, created by Facebook, allows us to offer visitors to our website targeted advertisements for our products on their platform.

  • Cookie

    mailpoet_suscriber

  • Duration

    Persistent

  • Description

    This cookie is used for abandoned cart emails.

  • Cookie

    mailpoet_page_view

  • Duration

    Persistent

  • Description

    Allows you to correctly calculate subscriber engagement and identify inactive subscribers. This cookie does not expire.

Reject
Confirm my selection
Cookies

This site uses cookies, deposited by our website, in order to improve your browsing experience. For more information on the purposes and to customize your preferences by type of cookies used, please visit our privacy policy page.

Accept all
Manage my preferences